St. James Investment Company LLC Acquires 3,874 Shares of GE HealthCare Technologies Inc. $GEHC

St. James Investment Company LLC grew its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.8% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 218,331 shares of the company’s stock after buying an additional 3,874 shares during the quarter. GE HealthCare Technologies makes up 2.6% of St. James Investment Company LLC’s portfolio, making the stock its 17th largest position. St. James Investment Company LLC’s holdings in GE HealthCare Technologies were worth $16,172,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Bessemer Group Inc. increased its stake in shares of GE HealthCare Technologies by 24.3% during the 1st quarter. Bessemer Group Inc. now owns 6,671 shares of the company’s stock worth $538,000 after purchasing an additional 1,306 shares during the last quarter. Flagship Harbor Advisors LLC increased its stake in shares of GE HealthCare Technologies by 17.4% during the 1st quarter. Flagship Harbor Advisors LLC now owns 3,443 shares of the company’s stock worth $278,000 after purchasing an additional 511 shares during the last quarter. Lineweaver Wealth Advisors LLC acquired a new position in shares of GE HealthCare Technologies during the 2nd quarter worth about $592,000. Wealth Enhancement Advisory Services LLC increased its stake in shares of GE HealthCare Technologies by 23.8% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 50,859 shares of the company’s stock worth $4,105,000 after purchasing an additional 9,769 shares during the last quarter. Finally, Exome Asset Management LLC acquired a new position in shares of GE HealthCare Technologies during the 1st quarter worth about $2,050,000. 82.06% of the stock is owned by institutional investors.

Analyst Ratings Changes

GEHC has been the topic of several recent analyst reports. Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Tuesday, October 14th. BTIG Research upped their price target on shares of GE HealthCare Technologies from $87.00 to $89.00 and gave the company a “buy” rating in a research note on Monday, October 13th. Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. Citigroup cut GE HealthCare Technologies from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $93.00 to $83.00 in a report on Tuesday, October 7th. Finally, Morgan Stanley set a $74.00 price target on GE HealthCare Technologies in a research note on Thursday, September 18th. Six equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $85.20.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ:GEHC opened at $76.10 on Wednesday. The company’s 50 day moving average price is $74.60 and its two-hundred day moving average price is $72.16. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $94.80. The firm has a market cap of $34.74 billion, a PE ratio of 15.59, a PEG ratio of 2.88 and a beta of 1.13. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The firm had revenue of $5 billion for the quarter, compared to analyst estimates of $4.96 billion. During the same quarter in the prior year, the business posted $1.00 EPS. The business’s revenue was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Equities research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be given a dividend of $0.035 per share. The ex-dividend date is Friday, October 24th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 2.87%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.